Janux Therapeutics, Inc. (JANX) Free cash flow 2020–2025
Janux Therapeutics, Inc. (JANX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$83.3MFY2025 · since FY2020: -$4.4M → -$83.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$83.3M | -88.5% |
| FY2024 | -$44.2M | +15.7% |
| FY2023 | -$52.4M | -6.2% |
| FY2022 | -$49.4M | -167.5% |
| FY2021 | -$18.5M | -322.5% |
| FY2020 | -$4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice